InsidersTradesSigma
Follow the Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Market capitalisation: €14.5bn. The latest transaction was disclosed on 25 June 2026 (Purchase). Among the most active insiders: 劉彥君. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Shanghai Bao Pharmaceuticals Co., Ltd. is a Shanghai-based pharmaceutical company focused on the development and manufacturing of pharmaceutical products. It is listed on the B market of H shares.